D-Wave Quantum: A Lawsuit Window, Two Cut Targets and a 15-Second Solver All Point to November 10
ServiceNow Weds AI Ambition to Governance as Investors Zero In on Contract Growth
Ubtech Robotics Puts Its Hardware to Work in Newsrooms, Factories and Showrooms
Marvell's Lumentum Bill Comes Due as Two Brokerages Trim Their Targets
Take-Two's November Reckoning: GTA VI Launch Hype Meets a Forecast That Must Carry the Rest
CATL's Overseas Battery Volumes Jump 46.7% as Storage Deals Multiply and Margin Pressure Bites
Amazon's Texas Nuclear Gambit Puts $220 Billion Spending Plan Under the Microscope
Axon's Skydio Bet Meets a Harsh Reception on Wall Street
Teradyne's Robotics Unit Turns Profitable as Sereact Tie-Up Targets Warehouse Workflows
Munich Re Shares Retreat 4% as JPMorgan Turns Neutral on 2027 Renewal Pricing
Diginex Puts Two Clocks on the Table: A Takeover Deadline and a Capital Vote One Day Apart
ASML's Order Book Runs to 2030, but Delivery Capacity Is the Bottleneck
Evotec's Horizon Savings Beat the Clock, but Deutsche Bank Won't Buy the 2030 Story
BioNTech Puts Its Cash to Work as Pipeline Delivers Mixed Readouts
Commerzbank's Record Nine-Month Haul Faces a Two-Front Test
Vertiv Locks Down Chip Supply as Its Order Book Runs at Triple-Digit Growth
Healthineers Puts Four New Board Names Forward as Olyrian Carve-Out and Siemens Split Take Shape
Berkshire's Buyback Brake: Price Discipline Meets a Weaker Underwriting Quarter
UniCredit Holds Capital Buffer Steady as Orlopp Backs Value Case for Commerzbank Tie-Up
Record Mine Output Masks a Shrinking Gold Supply as Central Banks Step Up
ABB's Robotics Sale Hits a Chinese Wall, and the Bill Comes Due
Sanofi Signals Appetite for Bigger Deals as Analysts Lift Targets
Apple's $7.5 Billion Bond Lands as Wall Street Rewrites Its Profit Math
IBM's Quantum Bet Meets Its Auditor as Cloud and AI Tools Roll Out
IREN's $20.3 Billion Order Book Has No Penalty Clause for Late Delivery
Shell Offloads Australian Shelf Stake for $1.45 Billion as Buyback and LNG Deals Roll On
BASF's Evonik Stance Hardens as Analysts Tweak Targets and Buyback Rolls On
OHB's Order Book Meets Its Earnings Test: Sentinel-3 Option, Hera Milestones and a November Calendar
IonQ's Order Book Is Full. Its Gross Margin Is the Story Nobody Wants to Read
Aixtron's Order Book Is Doing the Talking While the Chip Sector Sets the Volume
Argus Lifts Pfizer Target to $40 as Pipeline Wins Meet a Muted Market
CoreWeave's $129 Billion Backlog Meets Its Toughest Test: Turning Contracts Into Cash